The impact of comorbidities and substance use on heart failure events and major ventricular arrhythmias in phospholamban p.(Arg14del) positive individuals.

Back

EHRA Premium Access

The impact of comorbidities and substance use on heart failure events and major ventricular arrhythmias in phospholamban p.(Arg14del) positive individuals.

Session: Poster session on ventricular tachycardia, others

Topic: Genetic Aspects of Arrhythmias

Speaker: Miss M. Van Der Heide (Amsterdam, NL)

Event: EHRA 2024

Congress Presentation

Add to my library

About the speaker

Miss Myrthe Van Der Heide

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))

0 follower

105 more presentations in this session

Clinical accuracy of a 3-dimensional multielectrode non-invasive ECG mapping vest in premature ventricular contraction ablation procedures

Speaker: Associate Professor B. Hunuk (Istanbul, TR)

Stereotactic arrhythmia radioablation for refractory ventricular tachycardia. A retrospective analysis and optimisation of the planning phase.

Speaker: Mr J. Solana Munoz (Lausanne, CH)

Access

Abstract

Electrophysiological characteristics of tachyarrhythmia and effects of catheter ablation in patients with Fontan circulation

Speaker: Assistant Professor J. Uhm (Seoul, KR)

Access

Abstract

Accuracy of pace-mapping using an automated template matching module for site of origin identification of idiopathic outflow tract premature ventricular contractions

Speaker: Doctor N. Schaerli (Basel, CH)

Epicardial catheter ablation of ventricular tachycardia in patients of acm - from a university hospital report in switzerland

Speaker: Doctor F. Guan (Zurich, CH)

Access the full session

Poster session on ventricular tachycardia, others

Speakers: Miss M. Van Der Heide, Associate Professor B. Hunuk, Mr J. Solana Munoz, Assistant Professor J. Uhm, Doctor N. Schaerli...

Access

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources